VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COMy 2019 | Risk stratification of MGUS

Monoclonal gammopathy of unknown significance effects 3-4% of the general population, 50 years of age and above. Vincent Rajkumar, MD from the Mayo Clinic, Rochester, MN, presents methods to stratify the risk of disease progression to multiple myeloma. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter